Hantavirus headlines jolt biotech and pharma stocks as traders crowd into vaccine names
Reports of Hantavirus cases on a cruise ship sparked a sharp, if brief, rally in select biotech and pharma stocks as investors rotated into vaccine and diagnostic plays. Here’s what drove the volatility, what changed from the recent baseline, and how different investors might position.